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AbsTrACT
Objective Many studies examining stroke outcomes 
focus on more severe strokes or have short follow-up 
periods, so the long-term outcomes post-minor ischaemic 
stroke are unclear.
Methods We recruited participants from inpatient 
and outpatient services with a lacunar or minor cortical 
ischaemic stroke (National Institutes of health stroke 
scale score <8) and assessed current and premorbid 
cognitive functioning (addenbrooke’s cognitive 
examination–Revised (ace-R), National adult Reading 
Test (NaRT)), physical functioning (Timed Get Up 
and Go (TUG), 9-hole peg Test (9hpT)), dependency 
(modified Rankin scale (mRs)), depression (Beck’s 
Depression Inventory) in-person and remotely (stroke 
Impact scale).
results We followed up 224/264 participants at 3 years 
(mean age at index stroke=67, 126 (56%) men, 25 non-
contactable, 15 declined): 66/151 (44%) had cognitive 
impairment, mean ace-R 88 (sD 9, range 54–100/100), 
61/156 (39%) had depression and 26/223 (12%) were 
dependent (mRs=3–5). cognitive impairment at 3 years 
affected all ace-R subdomains and was associated with 
ace-R 1 year (β=1.054, p<0.001) and NaRT (β=1.023, 
p<0.05). poor physical function was associated with 
stroke severity (TUG, β=1.064, p<0.01) and recurrent 
stroke (9hpT, β=1.130, p<0.05 right, β=1.214, p<0.05 
left). higher ace-R scores were associated with faster 
TUG (β=−0.279, p<0.05) and 9hpT (right β=−0.257, 
p<0.05; left β=−0.302, p=0.05) and inversely with 
dependency (mRs=3–5, OR 0.88, 95% cI 0.80 to 0.97). 
We adjusted analyses for demographic, stroke and 
known risk factors. In-person and remote assessments 
were highly correlated.
Conclusions cognitive, physical impairments and 
depression are common and interrelated 3 years after 
minor stroke. cognitive and physical impairments require 
rehabilitation after minor stroke and argue for better 
integration of stroke and dementia services.
Stroke is a common cause of disability in adults in 
high-income countries. Two-thirds of stroke survi-
vors in the UK will have some disability1 and a 
third will be dependent. Stroke is associated with 
impairments in mobility,2 gait and balance3 and 
poor dexterity,1 as well as cognitive impairment and 
dementia.2 4–6 These impairments lead to decreased 
quality of life, low mood and increased mortality, 
dependency and disability.4 Risk factors for post-
stroke physical and cognitive impairment overlap 
and include older age, lower premorbid intelligence 
(IQ), lower education and more vascular risk factors 
(eg, atrial fibrillation (AF) and diabetes).5 7
Although many studies have documented 
stroke risk factors and outcomes, most have short 
follow-up periods and do not focus on minor 
stroke. Pendlebury and colleagues5 found that in 21 
hospital-based studies of post-stroke dementia, only 
4 (19%) had a follow-up period of 2 or more years, 
7 (33.33%) were longitudinal and most included 
patients with varying severities, mainly moderate 
strokes.5 8 Patients with minor stroke, while less 
likely to be physically disabled, may have cognitive 
impairment that restricts their return to full inde-
pendent function,9 but their long-term outcomes 
are unclear. Furthermore, data on associations 
between cognitive and physical function, depen-
dency and post-stroke comorbidities like depression 
are also limited, restricting long-term planning for 
minor ischaemic stroke.
We aimed to document physical and cognitive 
impairment and dependency outcomes at 3 years 
post-minor ischaemic stroke, including any associ-
ations between outcomes and specific independent 
risk factors. We also compared direct in-person 
with indirect (postal/phone) assessments of several 
domains.
MeThOds
Participants
In this prospective study, we recruited patients with 
minor ischaemic stroke (details described previ-
ously).6 Briefly, we recruited inpatients and outpa-
tients consecutively assessed by the Lothian Stroke 
Services, Scotland, and diagnosed with minor isch-
aemic stroke between May 2010 and May 2012 
into the Mild Stroke Study 2 (MSS2).
Minor ischaemic stroke was defined as a focal 
onset of neurological symptoms lasting >24 hours, 
with no other explanation, a National Institutes of 
Health Stroke Scale (NIHSS) score of <8 and not 
expected to result in dependency (modified Rankin 
Scale (mRS) score <3). Stroke was confirmed by 
an expert panel based on clinical findings and MRI 
and subtyped as ‘cortical’ or ‘lacunar’ based on clin-
ical stroke syndrome.10
Follow-up
All participants were invited for follow-up at 1 and 
3 years’ post-index stroke. At 3 years, we contacted 
the general practitioner (GP) to ascertain if the 
participant was alive before sending a brief ques-
tionnaire assessing new diagnoses since the 1-year 
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follow-up. We invited participants to attend a face-to-face 
assessment by a trained researcher. Where participants could not 
attend, we offered home visits or telephone interviews. Every 
effort was made to follow up all participants. Where participants 
did not respond, we sought further information from the GP and 
hospital records, and sought cause of death from hospital records 
and death certificates for participants who were deceased.
Assessments
The initial follow-up questionnaire collected information on 
vascular events (eg, stroke, transient ischaemic attack (TIA) 
and myocardial infarction (MI)), new diagnoses of vascular risk 
factors and lifestyle factors (eg, smoking and alcohol use) since 
1 year of follow-up.
We collected sociodemographic information including socio-
economic status in adulthood (eg, occupation, living situation) 
and childhood (eg, address, size of house and number of people 
living in their home at age 11), and education (secondary school 
or less/further education following secondary school).
We assessed recovery from stroke using the mRS (6=deceased), 
Clinical Dementia Rating Scale (CDR),11 Stroke Impact Scale 
(SIS)12 and European Quality of Life (EQ-5D-5L) scale.13 When 
SIS Emotion Domain responses were inconsistent (eg, feel 
sad=‘none of the time’ and feel like life is worth living=‘none of 
the time’) and the participant could not be contacted for confir-
mation, responses were removed (n=10).
Participants who were not seen for in-person assessment (due 
to illness or no longer living in the area) were invited to complete 
the SIS, EQ-5D-5L and sociodemographic questionnaire by post 
or phone (figure 1 indicates subjective/self-reported and objec-
tive/in-person measures).
For those seen in person, we assessed current cognition using 
the Montreal Cognitive Assessment (MoCA),14 Addenbrooke’s 
Cognitive Examination–Revised (ACE-R)15 and Mini-Mental 
State Examination (MMSE)16 and premorbid IQ using the 
National Adult Reading Test (NART), which provided a stan-
dardised estimate of peak cognitive performance in early adult-
hood.17 Where possible, an informant provided information 
on prestroke changes in cognition using the Informant Ques-
tionnaire of Cognitive Decline in the Elderly.18 We assessed 
depression using Beck’s Depression Inventory (BDI).19 When 
participants did not provide a response to question 21 (Loss of 
interest in sex) citing it was not applicable (eg, partner deceased), 
a score of 0 was assigned (n=12).
We measured physical functioning using the Timed Get Up 
and Go (TUG),20 where participants rise from a chair, walk 3 
metres and back returning to a seated position, and the Nine 
Hole Peg Test (9HPT)21 where participants remove nine small 
pegs one at a time before replacing them. Both tasks are timed.
statistical analysis
We analysed cognitive and physical functioning as contin-
uous variables. Where applicable, we categorised scores based 
on established cut-offs. MoCA scores ≥26 were considered 
normal.14 ACE-R scores were grouped into severe (≤82), mild 
(83-88) and no cognitive impairment (≥89).15 Several cut-offs 
exist for the MMSE. We considered scores ≥27 as normal.22 
We used Mann-Whitney U test (U) to compare groups based on 
levels of cognitive impairment on subscales of the ACE-R and 
MoCA to determine whether any specific deficit was driving this.
We used linear regression to examine predictors of cognitive 
and physical functioning and the relationship between these 
outcomes. Where appropriate, we controlled for known risk 
factors including demographic (eg, age, sex, further education 
and occupation), stroke (eg, stroke subtype and stroke severity), 
vascular risk factors (eg, hypertension, diabetes, hyperlipi-
daemia and AF) and lifestyle variables (eg, smoking and alcohol 
consumption). Some outcome variables were log transformed to 
avoid non-normal data and back transformed for reporting.
We used multinomial logistic regression to examine risk factors 
for disability (mRS). We grouped participants into no disability 
(mRS=0), no disability but symptoms present (mRS=1), slight 
disability (mRS=2), moderate to severe disability (mRS=3–5) 
and deceased (mRS=6). Based on the most complete available 
data, we included age at index stroke, sex, stroke type, index 
stroke severity, recurrent stroke, vascular risk factors and self-re-
ported subjective cognitive difficulties at 1 year (yes/no) as 
predictors.
resulTs
At baseline, 264 patients with clinically confirmed minor isch-
aemic stroke were recruited.6 At 3 years post-stroke, all living 
participants were followed up and 202/264 (77%) provided 
data either in person (157, 78%) or by post or phone (45, 22%; 
figure 1). Those who participated at 3 years (n=202) were more 
likely to have self-reported subjective cognitive difficulties at 1 
year than those without follow-up. There were no significant 
differences in demographic or index stroke characteristics.
Of the 62 participants without follow-up data, 25 (40%) were 
not contactable, 15 (24%) declined and 22 (3%) were deceased. 
Causes of death included cancer (n=13), recurrent stroke (n=3), 
MI (n=2), heart failure, pulmonary fibrosis, sepsis and unknown 
(all n=1). As such, outcomes were available for 224 (202 with 
follow-up data and 22 deceased)/264 (85%) participants, with 
mean age at index stroke=67, and 126 (56%) men. Of these, 
29/223 (13%) experienced a further vascular event including 
21 (9%) with recurrent stroke or TIA and 8 (4%) with MI. A 
new diagnosis of hypertension, hyperlipidaemia, diabetes and/
or AF was reported by 67 (30%) participants since the 1-year 
follow-up (table 1, online supplementary table 1).
Cognition
We assessed cognitive functioning in 153/157 (97%) participants 
seen for in-person assessment. Reasons for no cognitive assess-
ment included visual impairment, English as a second language, 
declined and not completed (all n=1).
Scores on the MoCA (n=153) ranged from 10 to 30/30 
(M=25.15, SD 4.03) with impairment (MoCA <26) in 71 
(46%) participants. Scores on the MMSE (n=153) ranged 
from 16 to 30/30 (M=27.96, SD 2.48) with impairment in 28 
(18.3%) participants. Scores on the ACE-R (n=151) ranged 
from 54 to 100/100 (M=88.32, SD 8.92) with severe impair-
ment (ACE-R ≤82) in 31 (21%), mild impairment (ACE-R=83–
88) in 35 (23%) and normal cognition in 85 (56%) participants 
(figure 2). Those with impairment showed significantly poorer 
performance across all subscales compared with those with no 
impairment on the ACE-R and MoCA (table 2).
Scores on the CDR (n=157) ranged from 0 to 1/3. Question-
able (CDR=0.5) and mild (CDR=1) symptoms of dementia 
were reported in 75 (48%) and 8 (5%) participants, respectively 
(figure 2). No symptoms of dementia (CDR=0) were reported 
in the remaining 74 (47%).
Age (β=−0.306, 95% CI −0.181 to −0.042), male sex 
(β=−0.191, 95% CI −2.966 to −0.164), premorbid IQ 
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Figure 1 Flow diagram for data collection in the Mss2 3-year follow-up. *Number with self-reported modified Rankin scale. †scores of 6 are based 
on those deceased at 3-year follow-up. ‡self-reported/subjective measure. §In-person/objective measure. ace-R, addenbrooke’s cognitive examination–
Revised; eQ-5D-5L, european Quality of Life scale; FU, follow-up; MMse, Mini-Mental state examination; Moca, Montreal cognitive assessment; Mss2, 
Mild stroke study 2; NaRT, National adult Reading Test; 9hpT, Nine hole peg Test; sIs, stroke Impact scale; TUG, Timed Get Up and Go.
(NART; β=0.344, 95% CI 0.063 to 0.260), MoCA scores at 
1 year (β=0.368, 95% CI 0.188 to 0.639) and hypertension 
(β=0.328, 95% CI 0.864 to 5.571) predicted MoCA scores 
at 3 years. Age (B=0.980, p<0.001), ACE-R scores at 1 year 
(B=1.054, p<0.001) and premorbid IQ (NART; B=1.023, 
p<0.05) predicted ACE-R scores at 3 years. Sex, further educa-
tion, adult SES, vascular risk factors and lifestyle factors did not 
significantly contribute (table 3).
depression
Depression scores (BDI; n=156) ranged from 0 to 49/63 
(M=9.81, SD 9.12) with mild depression (BDI=10–18) in 
35 (22%), moderate (BDI=19–29) in 61 (39%) and severe 
(BDI=30–63) in 6 (34%) participants. The remaining 95 (61%) 
scored within the normal range. Higher BDI scores were asso-
ciated with male sex (β=0.705, p<0.05) and recurrent stroke 
(β=1.659, p<0.01). No other demographic, stroke or lifestyle 
variables significantly contributed.
Physical outcomes
Physical functioning was assessed in 153/157 (97%) participants 
seen for in-person assessment. Four did not complete the 9HPT 
(poor vision (n=2), ran out of time and did not consent (both 
n=1)) and 12 did not complete the TUG (mobility difficulties 
(n=6), did not consent or declined (n=4), ran out of time and 
other (both n=1)).
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Table 1 Descriptive statistics at 3-year follow-up
Variable N descriptive
Demographics 
Age at index stroke 224 67.13±11.49
Sex: male n (%) 224 126 (56.25)
Further education: yes n (%) 159 65 (29.15)
Adult SES n (%) 157
  High 49 (31.21)
  Middle 49 (31.21)
  Low 59 (37.58)
Premorbid IQ 153 112.2±8.44
Stroke characteristics 
Stroke type n (%) 224
  Cortical 131 (58.48)
  Lacunar 93 (41.52)
NIHSS worst 224 2.34 (1.32)
3-year outcomes 
Further vascular event: yes n (%)*† 224
  Stroke or TIA 21 (9.37)
  MI 8 (3.57)
Disability: mRS† n (%) 217
  No symptoms 54 (24.88)
  No significant disability 69 (31.80)
  Slight disability 46 (21.20)
  Moderate disability 14 (6.45)
  Moderate/severe disability 9 (4.15)
  Severe disability 3 (1.38)
  Dead 22 (10.14)
Cognition‡ 
  ACE-R 151 88.32±8.92
  MoCA 153 25.15±4.03
  MMSE 153 27.96±2.48
BDI‡ 156 9.81±9.12
Physical functioning‡ 
  TUG 145 11.91±4.61
  9HPT-right 153 28.18±11.68
  9HPT-left 153 31.05±15.42
Descriptive statistics are either ±mean and SD or n (%).
*Since 1-year follow-up and including those with further vascular events as cause 
of death.
†Subjective/self-reported.
‡Objective/in-person assessment.
ACE-R, Addenbrooke's Cognitive Examination - Revised; BDI, Beck's Depression 
Inventory; 9HPT, Nine Hole Peg Test; MI, Myocardial Infarction; MMSE, Mini Mental 
State Examination; MoCA, Montreal Cognitive Assessment; NIHSS, National 
Institutes of Health Stroke Scale; SES, Socioeconomic status; TIA, Transient 
Ischaemic Attack; TUG, Timed Get Up and Go; mRS, Modified Rankin Scale.
Scores on the TUG (n=145) ranged from 3 to 39 s (M=12, 
SD 5). Scores on the 9HPT (n=153) ranged from 14 to 110 s 
(mean=28, SD 12) and 16–149 s (M=31, SD 15) for right and 
left hand, respectively. Based on normative data for patients with 
acute stroke 6 months post-stroke,23 four (3%) participants were 
impaired on their right and seven (5%) on their left hand. Poorer 
TUG performance was associated with slower right-handed 
(β=0.086, p<0.05) and left-handed 9HPT times (β=0.201, 
p<0.05) when controlling for age, stroke severity and recurrent 
stroke.
When controlling for demographic, stroke characteristics, 
vascular factors and lifestyle variables, age and recurrent stroke 
predicted slower 9HPT right (β=1.011, p<0.001 and β=1.30, 
p<0.05, respectively) and left hand performance (β=1.012, 
p<0.001 and β=1.214, p<0.05, respectively). Slower TUG 
times were associated with age (β=1.009, p<0.01) and stroke 
severity (β=1.064, p<0.01; table 4).
Physical, cognitive and functional outcomes
When controlling for age, higher ACE-R scores were associated 
with faster TUG (β=−0.279, p<0.05) and 9HPT times (right 
hand: β=−0.257, p<0.05; left hand: β=−0.302, p=0.05). 
Lower ACE-R scores were associated with increased risk of 
moderate to severe disability (mRS=3–5; OR 0.88, 95% CI 0.80 
to 0.97) when controlling for age and premorbid IQ.
disability and recovery after stroke
Disability was measured using self-reported (n=217, including 
those who were deceased) and interviewer-reported mRS 
(n=156). Moderate to severe disability (mRS=3–5) was reported 
in 26/217 (12%) and 19/156 (12%) participants in self-reported 
and in-person assessment, respectively (table 1).
Moderate to severe disability (mRS=3–5) was associated with 
age (OR 1.06, 95% CI 1.01 to 1.12), stroke severity (OR 2.29, 
95% CI 1.48 to 3.36), recurrent stroke (OR 5.25, 95% CI 1.63 
to 20.48) and self-reported cognitive difficulties at 1 year (OR 
6.53, 95% CI 2.11 to 20.22). Death (mRS=6) was associated 
with age (OR 1.10, 95% CI 1.05 to 1.18). Sex, stroke type and 
vascular risk factors were not associated with disability. Self-re-
ported cognitive difficulties at 1 year were also associated with 
increased risk of symptoms without disability (mRS=1; OR 
3.00, 95% CI 1.31 to 6.82) and slight disability (mRS=2; OR 
5.10, 95% CI 2.05 to 12.68).
In-person versus indirect assessments
We used the SIS (n=166) and EQ-5D-5L (n=163) to measure 
self-reported post-stroke recovery with higher scores indicating 
better functioning. Overall, self-reported functioning was good 
with median scores of 1/5 across the EQ-5D-5L domains and 
average scores on the SIS domains ranging from 82.27/100 
(Strength Domain) to 90.34/100 (Communication Domain; 
online supplementary table 1).
Higher ACE-R scores (β=0.41, bootstrapped (2000 repli-
cations) 95% CI 0.33 to 1.32) were associated with better SIS 
Memory domain scores when controlling for age and premorbid 
IQ. Faster TUG performance was associated with better SIS 
Mobility domain scores (β=−0.63, 95% CI −2.87 to −1.86) 
and faster right and left 9HPT performance was associated 
with better SIS Hand Function domain scores (β=−0.40, boot-
strapped (2000 replications) 95% CI −1.06 to −0.46 and 
β=−0.48, bootstrapped (2000 replications) 95% CI −0.91 
to −0.46, respectively) when controlling for age. Lower SIS 
Emotion domain scores were associated with higher BDI scores 
(β=−0.77, 95% CI −1.80 to −1.37).
dIsCussION
This prospective, long-term study of outcomes at 3 years post-
minor ischaemic stroke, at an average age of 67, identified 
impairments in cognitive functioning in almost half (47%) of 
the 153/202 patients available for the assessment, with around a 
third being impaired in physical functioning, 13% having mRS 
score indicating dependency and 29/224 (13%) having a further 
TIA/minor stroke or MI between 1 and 3 years of follow-up. 
Cognitive dysfunction affected all subdomains of the ACE-R, 
was consistent across all measures of current cognition, and 
was associated with higher levels of physical dysfunction and 
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Figure 2 Frequency of cognitive impairment by measure. ace-R, addenbrooke’s cognitive examination–Revised; cDR, clinical Dementia Rating scale; 
MMse, Mini-Mental state examination; Moca, Montreal cognitive assessment.
Table 2 Differences between those with versus without cognitive 
impairment by subscales
u† r
ACE-R
  Attention and orientation 4164* −0.49
  Memory 5218.5* −0.74
  Fluency 5049.5* −0.69
  Language 4493.5* −0.54
  Visuospatial 4159* −0.44
MoCA
  Orientation 2232* −0.32
  Language 598.5* −0.70
  Executive 1295* −0.51
  Language 1456* −0.49
  Visuospatial 1615* −0.43
*p<0.001.
†Mann-Whitney U Test.
ACE-R, Addenbrooke’s Cognitive Examination–Revised; MoCA, Montreal Cognitive 
Assessment.
disability. Lower premorbid IQ, poorer cognition at 1 year and 
older age predicted cognitive dysfunction, while index stroke 
severity and recurrent stroke predicted physical dysfunction. 
Data on the long-term outcomes post-minor ischaemic stroke 
are sparse since most studies report outcomes at 3 to 6 months 
and include more severe strokes. We show that important long-
term negative consequences are common after minor stroke, 
particularly in cognition, even in a relatively young population 
with potentially >20 years’ life expectancy.
Cognition
Our findings using the ACE-R support previous research in 
(mostly) patients with acute stroke with a range of stroke sever-
ities at 1–5 years of follow-up (n=55)24 25 and reflect the global 
nature of this dysfunction found using full neuropsychological 
testing.26 Fluctuations in cognition shortly following stroke are 
common,26 but long-term improvements, particularly at 1 year, 
have been shown.26 27 As follow-up past 1 year is uncommon, it 
is not clear whether these improvements are temporary. Some 
evidence suggests that the risk of cognitive impairment increases 
for up to 5 years at a rate of 3% per year.5 However, these find-
ings are not specific to patients with minor stroke. Pre-stroke 
cognitive decline is associated with post-stroke cognitive 
decline.5 28 However, pre-stroke cognitive decline differs from 
premorbid IQ, the latter representing an individual’s peak cogni-
tive ability in early adulthood prior to any neurological damage 
or ageing effects. Premorbid or childhood IQ correlates strongly 
with adulthood intelligence,29 risk of cognitive impairment and 
dementia, particularly vascular dementia.30 Our findings show 
that lower premorbid IQ, but not necessarily pre-stroke cogni-
tive decline, is associated with higher risk of poorer cognition 
post-stroke.
The association between childhood/premorbid IQ and educa-
tion has been widely discussed and many use education as a proxy 
for IQ given its close relationship.31 However, the relationship 
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Table 3 Predictors of poor cognitive performance at 3-year follow-up
MoCA ACe-r
β se β se
Demographics 
  Age at onset −0.306* 0.035 0.98† 0.006
  Sex (male) −0.191‡ 0.704 0.963 0.118
  Further education (no) 0.071 0.758 0.834 0.133
  Premorbid IQ 0.344* 0.049 1.023‡ 0.010
  MoCA/ACE-R 1 year 0.368† 0.113 1.054† 0.011
  Adult SES 
   Middle −0.140 0.851 1.006 0.147
   Low −0.105 0.922 1.019 0.161
Stroke characteristics 
  Stroke subtype (lacunar) −0.054 0.677 1.065 0.120
  Stroke severity—worst (NIHSS) 0.018 0.238 0.968 0.042
  Recurrent stroke (yes) −0.122 0.762 0.912 0.134
Vascular factors 
  Diabetes 0.056 0.856 1.028 0.146
  Hypertension 0.328* 1.183 1.166 0.200
  Hyperlipidaemia 0.098 0.814 0.967 0.140
  Atrial fibrillation 0.110 0.779 1.020 0.137
Lifestyle factors 
  Smoker 
   Previous −0.004 1.122 1.118 0.198
   Current −1.645 0.735 1.074 0.125
  Alcohol (yes) 0.196 1.108 0.999 0.185
  Overall model fit (R2adjusted) 0.490 0.597
Multivariate analysis controlling for all variables included in the table.
*p<0.01.
†p<0.001.
‡p<0.05.
ACE-R, Addenbrooke’s Cognitive Examination–Revised; MoCA, Montreal Cognitive 
Assessment; NIHSS, National Institutes of Health Stroke Scale; SES, socioeconomic 
status.
between these variables is complex and few studies have exam-
ined their independent association with health outcomes, partic-
ularly with stroke. We show that premorbid IQ (as measured 
by NART) associated with post-stroke cognition, independent of 
the education. At the 1-year follow-up, both NART and years of 
education were significant independent predictors32 suggesting 
that these variables should be treated separately. However, our 
education variable may lack statistical power; therefore, further 
research is needed to determine the independent association of 
these variables with stroke risk and outcomes.
Although previous research has shown significant associations 
between stroke severity and cognition,5 we do not find these 
associations to be significant in our cohort. This is likely due to 
the small range in stroke severities included in this study.
Physical functioning
Physical functioning varied greatly, particularly on the 9HPT. 
Although no published norms for patients with stroke on the 
TUG exist, several studies including patients with stroke of a 
similar age used a cut-off of 12 s.33 Based on this, 46 (32%) 
participants in the MSS2 would be classified as impaired. 
Furthermore, 37% of participants reported some degree of 
disability (mRS ≥2) indicating loss of independence and difficul-
ties in activities of daily living (ADL).
Although hand dysfunction is common in patients with 
stroke,34 35 comparison of 9HPT scores with normative data 
for patients 6 months post-stroke showed that impairments in 
dexterity were uncommon in the MSS2.23 These findings were 
supported by generally high SIS Hand Function scores. We were 
unable to identify any studies which examined dexterity, gait 
and walking speed in patients with minor stroke after more than 
6 months, so it is possible that hand functioning continues to 
improve; the association between poorer 9HPT and recurrent 
stroke in the MSS2 supports the suggestion that hand func-
tioning is sensitive to the impact of stroke.
strengths and limitations
We followed up 224/264 participants (85%) at 3 years post-
stroke. Most were seen in-person, but where this was not 
possible, questionnaire follow-up was conducted by phone 
or post to maximise response rate. We found no differences 
between those with and without follow-up. Our follow-up was 
comprehensive, assessing physical and cognitive functioning, 
subjectively and objectively, and causes of death. This allowed 
us to determine the rates of difficulties experienced in daily life 
as well as the difficulties that would be seen by clinicians. The 
large sample allowed us to adjust for potential confounders and 
test for independent risk factors relevant to clinical practice and 
patients.
We used cognitive screening tools sensitive to detecting 
impairment in patients with stroke24 and assessed premorbid 
IQ. Cognitive screening tools are quick and easy to administer 
but may lack sensitivity to impairments in other areas of cogni-
tion (eg, processing speed and areas of executive functioning). 
Detailed neuropsychological testing would be needed to deter-
mine the full effects of minor stroke; however, this would 
increase assessment time, participant burden, fatigue and risk of 
missing data.
We defined minor ischaemic stroke using an NIHSS score <8; 
however, many definitions exist.36 An NIHSS score ≤3 has been 
associated with favourable short-term and long-term outcomes 
and has been suggested as a reliable definition.36 In our sample, 
202/264 (77%) met this criteria at baseline (158/202, 78% at 
3 years’ follow-up). Participants with follow-up and cognitive 
and physical assessment did not differ on the initial NIHSS 
compared with those without. We controlled for stroke severity 
in our analyses; therefore, it is unlikely that our findings are 
influenced by those with more severe strokes.
Individuals unable to undergo MRI at baseline were excluded, 
which may have introduced bias in our sample. However, this 
is likely to be minimal as we include patients with minor stroke 
only and contraindications to MRI were not related to index 
stroke characteristics.
Implications
Physical dysfunction is frequently the focus in post-stroke clin-
ical practice as difficulties are more obvious as stroke severity 
increases. We show that those with minor stroke, hence less 
obvious physical dysfunction, experience high levels of disability 
and difficulties in ADL. Furthermore, identification of those 
with physical dysfunction, via risk factors such as stroke severity 
and recurrent stroke, may help identify those with cognitive 
impairment, even when the impairment is mild.
Importantly, cognitive dysfunction, though common, could 
easily go unnoticed without objective assessment. Even when 
mild, cognitive dysfunction can have a substantial impact on the 
patient’s independence and ability to monitor and control other 
risk factors (eg, take antihypertensive medications, maintain a 
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Table 4 Predictors of poor physical functioning and higher depression scores at 3-year follow-up
TuG 9hPT—right hand 9hPT—left hand bdI
β se β se β se β se
Demographics 
  Age at onset 1.009* 0.003 1.011† 0.002 1.012† 0.003 1.009 0.008
  Sex (male) 1.024 0.059 1.079 0.049 1.108 0.052 0.705‡ 0.153
  Further education (no) 0.970 0.066 0.968 0.053 0.985 0.058 0.998 0.168
  Adult SES 
   Middle 1.072 0.074 1.028 0.061 1.014 0.065 0.994 0.191
   Low 1.049 0.075 1.059 0.062 0.968 0.066 1.228 0.192
Stroke characteristics 
  Stroke subtype (lacunar) 1.052 0.061 1.062 0.051 1.039 0.054 0.866 0.156
  Stroke severity—worst (NIHSS) 1.064* 0.023 1.023 0.018 1.011 0.019 1.068 0.055
  Recurrent stroke (yes) 1.023 0.067 1.130‡ 0.055 1.214‡ 0.058 1.659* 0.169
Vascular factors 
  Diabetes 1.103 0.076 0.917 0.063 1.049 0.067 0.945 0.195
  Hypertension 0.924 0.101 1.003 0.086 0.871 0.091 0.865 0.267
  Hyperlipidaemia 0.924 0.073 0.941 0.059 0.882‡ 0.063 0.966 0.183
  Atrial fibrillation 1.002 0.071 1.005 0.059 1.009 0.063 0.981 0.182
Lifestyle factors 
  Smoker 
   Previous 1.030 0.089 1.013 0.074 1.056 0.080 1.358 0.234
   Current 0.973 0.067 1.048 0.056 1.044 0.060 1.336 0.174
  Alcohol (yes) 0.959 0.086 0.922 0.069 0.891 0.075 0.620 0.213
  Overall model fit (R2adjusted) 0.044 0.148 0.195 0.140
Multivariate analysis controlling for all variables included in the table.
*p<0.01,
†p<0.001.
‡p<0.05.
BDI, Beck's Depression Inventory; 9HPT, Nine Hole Peg Test; NIHSS, National Institutes of Health Stroke Scale; SES, socioeconomic status; TUG, Timed Get Up and Go.
healthy diet) and thus maintain brain health.37 These findings 
highlight the multidimensional effects of stroke and the possible 
benefits of considering premorbid IQ when determining risk of 
post-stroke cognitive dysfunction.
suMMAry
Studies examining the long-term cognitive and physical outcomes 
following minor ischaemic stroke are sparse. Our findings show 
long-term cognitive and physical dysfunction is common and 
that cognition may further negatively impact on their physical 
function and on their ADL. More research is required to iden-
tify the changes in functioning over the course of recovery post-
minor stroke to help better understand their trajectories.
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